Antibiotic resistance profiles and multidrug resistance patterns of Streptococcus pneumoniae in pediatrics: A multicenter retrospective study in mainland China
- PMID: 31192930
- PMCID: PMC6587637
- DOI: 10.1097/MD.0000000000015942
Antibiotic resistance profiles and multidrug resistance patterns of Streptococcus pneumoniae in pediatrics: A multicenter retrospective study in mainland China
Abstract
Emergent resistance to antibiotics among Streptococcus pneumoniae isolates is a severe problem worldwide. Antibiotic resistance profiles for S pneumoniae isolates identified from pediatric patients in mainland China remains to be established.The clinical features, antimicrobial resistance, and multidrug resistance patterns of S pneumoniae were retrospectively analyzed at 10 children's hospitals in mainland China in 2016.Among the collected 6132 S pneumoniae isolates, pneumococcal diseases mainly occurred in children younger than 5 years old (85.1%). The resistance rate of S pneumoniae to clindamycin, erythromycin, tetracycline, and trimethoprim/sulfamethoxazole was 95.8%, 95.2%, 93.6%, and 66.7%, respectively. The resistance rates of S pneumoniae to penicillin were 86.9% and 1.4% in non-meningitis and meningitis isolates, while the proportions of ceftriaxone resistance were 8.2% and 18.1%, respectively. Pneumococcal conjugate vaccine was administered to only 4.1% of patients. Penicillin and ceftriaxone resistance, underling diseases, antibiotic resistant risk factors, and poor prognosis appeared more frequently in invasive pneumococcal diseases. The incidence of multidrug resistance (MDR) was 46.1% in patients with invasive pneumococcal disease which was more than in patients with non-invasive pneumococcal disease (18.3%). Patients with invasive pneumococcal disease usually have several MDR coexistence.S pneumoniae isolates showed high resistance to common antibiotics in mainland China. Penicillin and ceftriaxone resistance rate of invasive streptococcal pneumonia patients were significantly higher than that of non-invasive S pneumoniae patients. Alarmingly, 46.1% of invasive clinical isolates were multidrug resistant, so it is important to continued monitor the resistance of S pneumoniae when protein conjugate vaccine (PCV13) is coming in mainland China.
Conflict of interest statement
No potential conflicts of interest to declare.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6587637/bin/medi-98-e15942-g002.gif)
Similar articles
-
A twenty years' results of the antimicrobial resistance profile and multidrug resistance trend of invasive Streptococcus pneumoniae isolates recovered from adult patients in Turkey: A literature review.Indian J Med Microbiol. 2022 Jul-Sep;40(3):342-346. doi: 10.1016/j.ijmmb.2022.06.004. Epub 2022 Jul 1. Indian J Med Microbiol. 2022. PMID: 35787332 Review.
-
Antimicrobial resistance profile and multidrug resistance patterns of Streptococcus pneumoniae isolates from patients suspected of pneumococcal infections in Ethiopia.Ann Clin Microbiol Antimicrob. 2021 Apr 20;20(1):26. doi: 10.1186/s12941-021-00432-z. Ann Clin Microbiol Antimicrob. 2021. PMID: 33879172 Free PMC article.
-
Molecular characterization, antibiotic resistance pattern and capsular types of invasive Streptococcus pneumoniae isolated from clinical samples in Tehran, Iran.BMC Microbiol. 2020 Jun 16;20(1):167. doi: 10.1186/s12866-020-01855-y. BMC Microbiol. 2020. PMID: 32546124 Free PMC article.
-
The changing phenotypes and genotypes of invasive pneumococcal isolates from children in Shenzhen during 2013-2017.Vaccine. 2019 Nov 20;37(49):7248-7255. doi: 10.1016/j.vaccine.2019.09.069. Epub 2019 Oct 18. Vaccine. 2019. PMID: 31635974
-
Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines.Clin Microbiol Infect. 2009 Apr;15 Suppl 3:4-6. doi: 10.1111/j.1469-0691.2009.02723.x. Clin Microbiol Infect. 2009. PMID: 19366362 Review.
Cited by
-
Serotype, antibiotic susceptibility and whole-genome characterization of Streptococcus pneumoniae in all age groups living in Southwest China during 2018-2022.Front Microbiol. 2024 Feb 1;15:1342839. doi: 10.3389/fmicb.2024.1342839. eCollection 2024. Front Microbiol. 2024. PMID: 38362498 Free PMC article.
-
In silico design of an epitope-based vaccine against PspC in Streptococcus pneumoniae using reverse vaccinology.J Genet Eng Biotechnol. 2023 Dec 12;21(1):166. doi: 10.1186/s43141-023-00604-8. J Genet Eng Biotechnol. 2023. PMID: 38085389 Free PMC article.
-
Discovery of novel phenanthridone derivatives with anti-streptococcal activity.Arch Microbiol. 2023 Nov 6;205(12):371. doi: 10.1007/s00203-023-03705-7. Arch Microbiol. 2023. PMID: 37930433
-
Severe problem of macrolides resistance to common pathogens in China.Front Cell Infect Microbiol. 2023 Aug 10;13:1181633. doi: 10.3389/fcimb.2023.1181633. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37637457 Free PMC article. Review.
-
Nasopharyngeal carriage and antimicrobial susceptibility profiles of Streptococcus pneumoniae among children with pneumonia and healthy children in Padang, Indonesia.Access Microbiol. 2023 Jun 16;5(6):acmi000584.v3. doi: 10.1099/acmi.0.000584.v3. eCollection 2023. Access Microbiol. 2023. PMID: 37424548 Free PMC article.
References
-
- Hackela M, Lascolsa C, Bouchillona S, et al. Serotype prevalence and antibiotic resistance in Streptococcus pneumoniae clinical isolates among global populations. Vaccine 2013;31:4881–7. - PubMed
-
- Wang CQ, Wang AM, Yu H, et al. Report of antimicrobial resistance surveillance program in Chinese children in 2016. Zhonghua Er Ke Za Zhi 2018;56:29–33. - PubMed
-
- Song JH, Thamlikitkul V, Hsueh PR. Clinical and economic burden of community-acquired pneumonia amongst adults in the Asia-Pacific region. Int J Antimicrob Agents 2011;38:108–17. - PubMed
-
- World Health Organization. Pneumococcal conjugate vaccine for childhood immunization--WHO position paper. Wkly Epidemiol Rec 2007;82:93–104. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical